Дифференциально-диагностические свойства и чувствительность к антибактериальным препаратам бактерий Pseudomonas aeruginosa

228. Hassan K.S., Al-Riyami D. Infective Endocarditis of the Aortic Valve caused by Pseudo-monas aeruginosa and Treated Medically in a Patient on Haemodialysis. SQU Med J. 2012. Vol.12: 120-123.

229. He Xianyuan. Cluster Analysis of 53 Chinese Antipyretic Herbs on Bacteriostatic Effects Against Pseudomonas aeruginosa / He Xianyuan, Li Kun, Yu Lurong, Liu Junkang, Liao Sixiang, Liu Yanxia // Chinese Journal of Experimental Traditional Medical Formulae. - 2014. - № 20. P. 82-85.

230. Hentzer M, Riedel K, Rasmussen TB, et al. Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiology. 2002;148(1):87-102

231. Hingst V. Investigations on the enzymatic degradation of formaede dy is lated of species Pseudomonas aeruginosa / V. Hingst, M. Maiwald, H.- G.Sonntad // Zbl. Dacteriol.- 1987.- B. 184.- № 2.-H. 167-181.

232. Hoiby N. Prospects for the prevention and control of pseudomonal infection in children with cystic fibrosis. Paediatrica Drugs. 2000;2(6):451-463

233. Holloway D.W. Bacteriophages and bacteriocines. In Geneties and Biochemistry of Pseudomonas (Eds P.H., Clarce and Richmond M.N. / D.W. Holloway, V. Krishnapillai // John Wiley.- London, 1975.

234. Homma J.Y. A nev antigenic shema and livecell stide agglutination procedure for the in infrasubspecific, serologic classification of Pseudomonas aeruginosa / J.Y. Homma // Areview Jap.J. exp. Med.- 1976.- V.46.- № 6.- P. 329-336.

235. Hoyle BD, Jass J. The biofilm glycocalyx as a resistance factor. Journal of Antimicrobial Chemotherary. 1990;26(1):1-5

236. Iglewski B.N. NAD- dependent inhibition of protein syn thems by Pseudomonas aeruginosa toxin / B. N. Iglewski, D. Kabat // Proc. Nate Fcad. Soi. USA.- 1975.- V. 72.- P. 2284-2288.

237. Iroha I. R. Bacteria contamination of raw meat sold in Abakaliki, Ebonyi State Nigeria / I. R. Iroha, E. C. Ugbo, D. C.Ilang, A. E. Oji, T. E. Ayogu // Journal of Public Health and Epidemiology. - 2011. - Vol. 3(2), pp. 49-53.

238. Ischida T., Ikeda T., Takiguchi N. et al. Inhibition of Quorum Sensing in Pseudomonas aeruginosa by N-Acyl Cyclopentylamides. Appl Environ Microbiol. 2007. Vol.73: 3183-3188.

239. Jackson T.L., Reykyn S.J., Graham E.M. Endogenous Bacterial Endophthalmitis: A 17-year Prospective Series and Review of 267 Reported Cases. Survey of Ophtalmology. 2008. Vol.48: 403-423.

240. Japoni A., Farshad S., Alborzi A. Pseudomonas aeruginosa: Burn Infection, Treatment and Antibacterial Resistance. Iranian Red Crescent Medical Journal. 2009. Vol.11: 244-253.

241. Jinsoo Song. Characterization of the pathogenesis Mechanism after Pseudomona aeruginosa infection through food consumption using chick embryo model / Jinsoo Song, Eun-Jung Jin, Kyoung -Hee Choi // Korean J. Food Sci. Ani. Resour. 2010. -Vol. 30. №4. Pp. 568-574.

242. Johes L.F. Pyocine typing Ps. aeruginosa: a simplified Method / L.F. Johes, I.P. Zacanicz, E.T. Thomas, I.I. Farmer // Appl. Microbiol.- 1974.- V.27.- № 2.- P. 400-406.

243. Jones L.F. Simplified method of producting pyocins from Ps. aeruginosa / L.F. Jones, B.V. Pinto, E.T. Thomas, I.I. Farmer // Appl. Microbiol.- 1973.- V. 26.- № l.P. 120-121.

244. Kleerebezem M, Quadri LE, Kuipers OP, et al. Quorum sensing by peptide pheromones and two-component signal-transduction systems in gram-positive bacteria. Molecular Microbiology. 1997;24:895-904

245. Kobayashi H. Basic and clinical study of bacterial biofilm. Nippon Naika Gakkai Zasshi. Abstract. 1994;83(9):1692-1696

246. Kobayashi H. Biofilm disease: its clinical manifestation and therapeutic possibilities of macrolides. American Journal of Medicine. 1995;99(6A):26S-30S

247. Kondoh K, Hashiba M. Inhibitory effect of macrolide antibiotics on biofilm formation by Pseudomonas aeruginosa. Nippon Jibiinkoka Gakkai Kaiho. Abstract. 1998;101(1):25-36

248. Kumon H, Ono N, Iida M, et al. Combination effect of fosfomycin and ofloxacin against Pseudomonas aeruginosa growing in a biofilm. Antimicrobial Agents Chemotherapy. 1995;39(5):1038-1044

249. Laffer R.R., Graber P., Ochsner P.E., Zimmerli W. Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. Clin Microbiol Infect. 2006. Vol.12: 433-439.

250. Lambert R.J., Hanlon G.W., Denyer S.P. The synergistic effect of EDTA/antimicrobial combinations on Pseudomonas aeruginosa. J Appl Microbiol. 2004. Vol.96: 244-253.

251. Liu P.V. The roles of various fractions of Ps. aeruginosa in ist pathogenesis / P.V. Liu // J. Infect. Dis.- 1961.- V. 108.- P.218-228.

252. Mah T.F., Pitts B., Pellock B. A genetic basis for Pseudomonas aeruginosa biofilm antibi-otic resistance. Nature. 2003. Vol. 426: 306-310.

253. Mandsberg L.F,Antibiotic resistance in Pseudomonas aeruginosa strains with increased muta-tion frequency due to inactivation of the DNA oxida-tive repair system / Mandsberg L.F, Ciofu O., Kirkby N., Christian­ sen L.E, Poulsen H.E., Hшiby N. Antimicrob Agents Chemother 2009; 53:2483 - 91.

254. Mathee K, Ciofu O, Sternberg C, et al. Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology. 1999;145(6):1349-1357

255. McLaughlin-Borlace L., Stapleton F., Matheson M., Dart J.K. Bacterial biofilm on contact lenses and lens storage cases in wearers with microbial keratitis. JAP. 1998. Vol,84: 827-838.

256. Meluleni G.J., Grout M., Evans D.J., Pier G.B. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients. J Immunol. 1995. Vol.155(4): 2029-2038.

257. Miller M.B., Bassler B.L. Quorum sensing in bacteria. Annu Rev Microbiol. 2001. Vol.55: 165-199.

258. Muh U., Schuster M., Heim R. et al. Novel Pseudomonas aeruginosa Quorum-Sensing In-hibitors Identified in an Ultra-High-Throughput Screen. Antimicrob. Agents Chemother. 2006. Vol.50: 3674-3679.

259. Mulcahy L.R., Isabella V.M., Lewis K. Pseudomonas aeruginosa biofilms in disease. Microb. Ecol. 2013. Vol.6: 76-79.

260. O'Toole G, Kaplan HB, Kolter R. Biofilm formation as microbial development. Annu Rev Microbiol. 2000. Vol.54: 49-79.

261. Pankey G.A., Sabath L.D. Clinical Relevance of Bacteriostatic versus Bactericidal Mecha-nisms of Action in the Treatment of Gram-Positive Bacterial Infections. Clin Infect Dis. 2004. Vol.38: 864-870.

262. Pasmans F. Modulation of interactions of Salmonella typhimurium with pigs bystress and T-2 toxin / F. Pasmans, S. Croubels, F. Haesebrouck // Faculty of Veterinary Medicine, Ghent University, Ghent. - 2012. - P. 11-169.

263. Pavlova I.B. Atlas: Pathogenic bacteria populations, in two parts / I.B. Pavlova // Pro Publishing House. - M., - 2014. - 352 p.

264. Pavlovskis O.R. Pseudomonas aeruginosa exotoxin in mice histopa- tholigy and Serum enzume changes /O.R. Pavlovskis, T.A. Voelken, A.N. Shacklford // J. Infect. Dis.- 1976.- V. 133.- P. 235-259.

265. Pavlovskis O.R. Pseudomonas aeruginosa exotoxin in mice: Localizationand effect on protein synthesis / O.R. Pavlovskis, A.N. Shackelford // Infect. Immun. - 1974.- V. 9.- № 3.- P. 540-546. 162.

266. Pearson JP, Van Delden C, Iglewski BH. Active efflux and difffusion are involved in transport of Pseudomonas aeruginosa cell-to-cell signals. The Journal of Bacteriology. 1999;181(4):1203-1210

267. Persek MR, Greenberg EP. Acy-homoserine Lactone quorum sensing in Gram-negative bacteria: A signaling mechanism involved in assciations with higher organisms. Proceedingd of the National Academy of Sciences of the United State of America. 2000;97(16):8789-8793

268. Petignat C., Francioli P., Nahimana I. et al. Exogenous Sources of Pseudomonas aeruginosa in Intensive Care Unit Patients: Implementation of Infection Control Measures and Follow-Up With Molecular Typing. infection control and hospital epidemiology. 2006. Vol.27 (9): 953-957.

269. Piddock L.J.V. N ewer mechanisms of resistance tolactam antibiotica of ® gram-negative bacteria / L.J.V. Piddock, R. Wise // J. Antimicrobiol. Chemoter.-1985.- V. 16.- № 3.. p. 273-284.

270. Pritt B., O`Brien L., Winn W. Mucoid Pseudomonas in Cystic Fibrosis. Am J Clin Pathol. 2007. Vol.128: 32-34.

271. Rashid HM, Rumbaugh K, Passador L, et al. Polyphosphate Kinase is essential for biofilm development, quorum sensing, and virulence of Pseudomonas aeruginosa. Proceedings of the National Academy of Sciences of the United State of America. 2000;97(17):9636-9641

272. Rashid MH, Rao NN, Kornberg A. Inorganic polyphosphate is required for motility of bactetial pathogens. The Journal of Bacteriology. 2000;182(1):225-227

273. Rashil MH, Rao NN, Kornberg A. Inorganic polyphosphate isneeded for swimming, swarming, and twitching motilities of Pseudomonas aeruginosa. Proceedings of the National Academy of Sciences of United State of America. 2000;97(9):4885-4890

274. Rhame F.S. Pseudomonas aeruginosa / F.S. Rhame // Ed. L.D. Sabath.- « Bern, 1980.-P. 31.-54.

275. Rocha C.L., Coburn J., Rucks E., Olson J. Characterization of Pseudomonas aeruginosa Exoenzyme S as a Bifunctional Enzyme in J774A.1 Macrophages. Infection and immunity. 2003. Vol.7: 5296-5305.

276. Rossolini G., Mantegoni E. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect. 2005. Vol.11: 17-32.

277. Saadia M. The microbial quality of fast food and traditional fast food / M. Saadia, Hassanein Easa // Nature and Science. - 2010. - № 8 (10). - Р. 117 - 133.

278. Sepandj F., Ceri H., Gibb A. уt ai. Minimum inhibitory concentration (MIC) versus mini-mum biofilm eliminating concentration (MBEC) in evaluation of antibiotic sensitivity of gram-negative bacilli causing peritonitis. Perit Dial Int. 2004. 24: 65-67Schmidmaier G., Lucke M., Wildemann B. et al. Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review. Injury. 2006. Vol.37: 105-112.

279. Shen Ying. Pseudomonas aeruginosa была обнаружена в образцах пищевых отравлений / Shen Ying, Yang Zhenglin, Yue Feng // Zhejiang Prev Med. 2010. - vol. 22. -№.3. Р. 45-46.

280. Song Z, Johansen HK, Moser C, et al.Effects of Chinese medicinal herbs on a rat model of chronic Pseudomonas aeruginosa Lung infection. Antimicrbial Agents and Chemotherapy. 1996;104:350-354

281. Stover C.K., Pham X.Q., Erwin A.L. et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature. 2000. Vol. 406: 959-964.

282. Tanaka G, Shigeta M, Shigeta M, Komatsuzawa H, et al. Effect of clarithromycin on Pseudomonad aeruginosa biofilms. Chemotherapy. 2000;46(1):36-42

283. Teitzel G., Parsek M. Heavy Metal Resistance of Biofilm and Planktonic Pseudomonas aeruginosa. Appl Environ Microbiol. 2003. Vol.69: 2313-2320.

284. Tetz G., Artemenko N., Tetz V. Effect of DNase and Antibiotics on Biofilm Characteristics. Antimicrob. Agents Chemother. 2009. Vol.53: 1204-1209.

285. Trampuz A., Widmer A.F. Infections associated with orthopedic implants. Current Opinion in Infectious Diseases. 2006. Vol.19: 349-356.

286. Trampuz A., Zimmerli W. Diagnosis and treatment of infections associated with fracture-fixation devices. Injury. 2006. Vol.37: 59-66.

287. Tomlin K.L., Coll O.P., Ceri H. Interspecies biofilms of Pseudomonas aeruginosa and Burkholderia cepacia. Can J Microbiol. 2001. Vol.47: 949-954.

288. Tre-Hardy M., Vanderbist F., Traore H. et al. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures. Int. J of Antimicrobial Agents. 2008. Vol.31: 329-336.

289. Van Delden C. Cell-to-cell sig-naling and Pseudomonas aeruginosa infections / C. Van Delden, B. H. Iglewski // Emerg. Infect. Dis. - 1998. - 4. - 551-560.

290. Van Loosdrecht MC, Lyklema J, Norde W, et al. Influence of interface on microbial activity. Microbiology Review. Review. 1990;54(1):75-87

291. Venturi V. Regulation of quorum sensing in Pseudomonas. FEMS Microbiol Rev. 2006. Vol. 30: 274-291.

292. Watters C., DeLeon K., Trivedi U. et al. Pseudomonas aeruginosa biofilms perturb wound resolution and antibiotic tolerance in diabetic mice. Med Microbiol Immunol. 2013. Vol.202: 131-141.

293. Walters M.C. 3rd, Roe F., Bugnicourt A. et al. Contributions of antibiotic penetration, oxy-gen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother. 2003. Vol.47: 317-333.

294. Whiteley M., Bangera M.G., Bumgarner R.E. et al. Gene expression in Pseudomonas aeruginosa biofilms. Nature. 2001. Vol.413: 860-862.

295. Widmer A.F. Infection control and prevention in the ICU. Intensive care medicine. 1994. Vol.20: 7-11.

296. Willcox M.D. Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review. Optom Vis Sci. 2007. Vol.84: 273-278.

297. Wu H., Song Z., Hentzer M. et al. Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice. J. Antimicrob. Chemother. 2004. Vol.53: 1054-1061.

298. Yanagihara K, Tomono K, Sawai T, et al. Efficacy of erythromycin inhalation in chronic respiratory infection caused by Pseudomonas aeruginosa. Kansenshogaku Zasshi. Abstract. 1997;71(4):337-341.

299. Zhang Xiaopan, Chen Ligang, Xu Yang etc. Determination of в-lactam antibiotics in milk based on magnetic molecularly imprinted polymer extraction coupled withliquid chromatography-tandem mass spectrometry // J. Chromatogr. B. 2010.878.№32,3421-3426.

300. He Lanxiang. The investigation reports of food poisoning caused by Pseudomonas aeruginosa / He Lanxiang, Huang Xinhua, Chen Caihong, Mao Zhiqu, Huang Yanting // China Rural Health. 2012

Размещено на Allbest.ru